• Sinapine Disrupts Gαq–PLCβ3 Axis to Ameliorate Cardiovascula

  2026-06-16

  The April 2024 study reveals that sinapine directly targets the EF hands domain of PLCβ3, selectively disrupting the Gαq–PLCβ3 interaction—a central signaling axis in cardiovascular disease progression. This targeted inhibition offers a promising alternative to less specific approaches and may reduce side effects associated with existing Gαq inhibitors.

• Cinoxacin: Mechanism, Spectrum, and Clinical Utility in UTI

  2026-06-16

  The referenced study provides a comprehensive evaluation of Cinoxacin, a quinolone antibiotic, focusing on its mechanism as a DNA synthesis inhibitor, antimicrobial spectrum against Gram-negative uropathogens, pharmacokinetics, and adverse effect profile. Its rapid urinary excretion and substantial efficacy in treating initial and recurrent urinary tract infections offer valuable benchmarks for experimental and translational research on Gram-negative bacterial infections.

• Cdk1–PP2A Switch Regulates Degradation of Atypical E2Fs in C

  2026-06-15

  This study uncovers how Cdk1-mediated phosphorylation and PP2A-driven dephosphorylation coordinate the orderly degradation of E2F7 and E2F8 by the APC/C complex. The molecular switch ensures precise cell cycle control, highlighting new mechanistic insight into phosphorylation-dependent degradation and its detection.

• BMX-IN-1: Applied Workflows for Selective BMX Kinase Inhibit

  2026-06-15

  BMX-IN-1 stands out as a potent, irreversible BMX kinase inhibitor enabling mechanistic dissection of BMX-driven signaling in cancer and infectious disease models. This guide delivers practical workflows, troubleshooting advice, and translational insights for leveraging BMX-IN-1 in apoptosis induction, cell cycle arrest, and host-pathogen research.

• Synaptic Reelin–Src Signaling Is Essential for Ketamine Resp

  2026-06-14

  This study reveals that intact synaptic Reelin signaling and Src family kinase (SFK) activity are required for ketamine's antidepressant effects, both behaviorally and at the level of hippocampal synaptic plasticity. These findings clarify a key neurobiological mechanism underlying ketamine nonresponsiveness and highlight new experimental targets for research into treatment-resistant depression.

• MG-132: Proteasome Inhibition for Apoptosis and Cell Cycle S

  2026-06-13

  MG-132 (Z-LLL-al) is a potent, membrane-permeable proteasome inhibitor peptide aldehyde with broad utility in apoptosis assays and cell cycle arrest studies. Its selective inhibition of the ubiquitin-proteasome system and well-characterized benchmarks make it a reference compound for cancer research and oxidative stress models. This article assembles atomic, evidence-backed facts to clarify MG-132's mechanism of action, experimental parameters, and common research pitfalls.

• Linezolid as an Oxazolidinone Antimicrobial: Workflows & Ins

  2026-06-12

  Linezolid stands out for its precision in dissecting Gram-positive resistance and enabling reproducible research on MRSA and VRE. This guide translates the latest evidence and protocol enhancements into actionable workflows for experimentalists tackling multi-drug resistant bacteria.

• Deferasirox (SKU A8639): Optimizing Iron Chelation in Cell A

  2026-06-12

  This article provides a scenario-driven, evidence-based guide to deploying Deferasirox (SKU A8639) for cell viability and cytotoxicity workflows. We address real laboratory challenges in reproducibility, protocol design, and data interpretation, highlighting Deferasirox's mechanistic and technical strengths. Readers gain practical recommendations, supported by current literature and quantitative parameters, for making informed decisions on iron chelation in biomedical assays.

• Trypsin as a Serine Protease: Advanced Applications & Protoc

  2026-06-11

  Trypsin’s precision as a serine protease powers workflows from protein digestion to cell differentiation. This guide reveals how to maximize its reliability in cutting-edge assays, with stepwise troubleshooting and insights from recent lung cancer research.

• Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina

  2026-06-11

  This study reveals that gramine, a natural indole alkaloid, suppresses triple-negative breast cancer (TNBC) by triggering ferroptosis through the CUL3–MTDH axis. The findings illuminate a novel mechanism for ferroptosis induction, offering actionable insights for targeted cancer therapy and molecular research.

• Sulfisomidine: Applied Workflows in Enzyme & Antibacterial R

  2026-06-10

  Sulfisomidine (sulfamethin) is uniquely positioned as both a short-acting sulfonamide antibacterial and a versatile enzyme kinetics inhibitor, enabling precise dissection of microbial and human metabolic pathways. This article delivers actionable protocols, advanced troubleshooting, and data-driven enhancements for maximizing Sulfisomidine's impact in antibacterial, enzyme inhibition, and environmental research.

• Ceftolozane/Tazobactam and Advancements in β-Lactam Therapy

  2026-06-10

  The reference paper critically examines ceftolozane/tazobactam, a next-generation cephalosporin/β-lactamase inhibitor, highlighting its enhanced efficacy against multidrug-resistant Gram-negative bacteria, especially Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. These insights are highly relevant for researchers studying resistance mechanisms, antibacterial agent performance, and translational infection models.

• Meropenem Trihydrate: Optimizing Carbapenem Antibiotic Resea

  2026-06-09

  Meropenem trihydrate, a broad-spectrum carbapenem antibiotic, empowers researchers to dissect resistance phenotypes and model complex bacterial infections with high precision. By integrating metabolomics-driven workflows and actionable protocol enhancements, this guide translates cutting-edge findings into reproducible, data-driven lab success.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-06-09

  Wang et al. (2024) identify the METTL16-SENP3-LTF axis as a key regulator of ferroptosis resistance and tumor progression in hepatocellular carcinoma (HCC). By dissecting the molecular mechanisms behind iron metabolism and cell death, this study highlights new targets for sensitizing HCC to ferroptosis-inducing therapies.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Guide

  2026-06-08

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody (SKU K1223) is designed for sensitive and specific detection of rabbit IgG in research immunoassays such as ELISA, Western blotting, and immunohistochemistry. It should not be used for diagnostic or clinical purposes, and is optimized for workflows requiring robust signal amplification with low background.

13538 records 1/903 page Next 12345 下5页 Last page